1. Home
  2. HYFT vs BUUU Comparison

HYFT vs BUUU Comparison

Compare HYFT & BUUU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HYFT
  • BUUU
  • Stock Information
  • Founded
  • HYFT 1983
  • BUUU 2017
  • Country
  • HYFT United States
  • BUUU Hong Kong
  • Employees
  • HYFT N/A
  • BUUU N/A
  • Industry
  • HYFT Biotechnology: Pharmaceutical Preparations
  • BUUU Services-Misc. Amusement & Recreation
  • Sector
  • HYFT Health Care
  • BUUU Consumer Discretionary
  • Exchange
  • HYFT Nasdaq
  • BUUU Nasdaq
  • Market Cap
  • HYFT 80.8M
  • BUUU 68.1M
  • IPO Year
  • HYFT 2017
  • BUUU 2025
  • Fundamental
  • Price
  • HYFT $1.69
  • BUUU $8.54
  • Analyst Decision
  • HYFT
  • BUUU
  • Analyst Count
  • HYFT 0
  • BUUU 0
  • Target Price
  • HYFT N/A
  • BUUU N/A
  • AVG Volume (30 Days)
  • HYFT 1.5M
  • BUUU 37.3K
  • Earning Date
  • HYFT 09-15-2025
  • BUUU 01-01-0001
  • Dividend Yield
  • HYFT N/A
  • BUUU N/A
  • EPS Growth
  • HYFT N/A
  • BUUU N/A
  • EPS
  • HYFT N/A
  • BUUU 0.04
  • Revenue
  • HYFT $18,214,531.00
  • BUUU $5,754,120.00
  • Revenue This Year
  • HYFT $19.93
  • BUUU N/A
  • Revenue Next Year
  • HYFT $32.15
  • BUUU N/A
  • P/E Ratio
  • HYFT N/A
  • BUUU $221.03
  • Revenue Growth
  • HYFT 18.33
  • BUUU 64.23
  • 52 Week Low
  • HYFT $0.27
  • BUUU $3.67
  • 52 Week High
  • HYFT $3.25
  • BUUU $9.50
  • Technical
  • Relative Strength Index (RSI)
  • HYFT N/A
  • BUUU N/A
  • Support Level
  • HYFT N/A
  • BUUU N/A
  • Resistance Level
  • HYFT N/A
  • BUUU N/A
  • Average True Range (ATR)
  • HYFT 0.00
  • BUUU 0.00
  • MACD
  • HYFT 0.00
  • BUUU 0.00
  • Stochastic Oscillator
  • HYFT 0.00
  • BUUU 0.00

About HYFT MindWalk Holdings Corp. Common Stock

MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.

Share on Social Networks: